Wednesday, November 13, 2024

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Search

Pfizer Agrees to Settle Zantac Cancer Lawsuits for $250 Million

by Rishma Parpia
Zantac pills
Pfizer, Inc., the largest pharmaceutical corporation in the world marketing drugs and vaccines, has agreed to pay between $200 to $250 million ...

Rapid Tests for Coronavirus Raise Concerns Over Accuracy

by Marco Cáceres
confused woman staring at paper
On Mar. 27, 2020, the U.S. Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) to pharmaceutical and medical ...

Anti-Depressants in Short Supply During COVID-19 Lockdowns

by Rishma Parpia
pills in hand
Drug shortages listed by the U.S Food and Drug Administration (FDA) are exposing some of the ramifications of responses to ...

Poll Finds Only Half of Americans Plan to Get COVID-19 Vaccine

by TVR Staff
refusing vaccine
A recent poll conducted by the Associated Press's NORC Center for Public Affairs Research found that 20 percent of Americans ...

COVID-19 Related Drug Shortage in U.S. Because China Supplies Most Ingredients

by Rishma Parpia
drugs from China
Story Highlights The FDA has reported its first drug shortage as a result of the COVID-19 outbreak in China. Many ...

Chinese Pharmaceutical Industry Competes for Vaccine Market Share

by Kate Raines
Chinese vaccine researcher
China’s National Medical Products Administration has announced that two Chinese pharmaceutical companies, Walvax Biotechnology and Innovax, have been approved to ...

Tamiflu on Track to Be an Over-The-Counter Drug

by TVR Staff
capsule
In July 2019, drug and French vaccine manufacturer Sanofi signed a deal with Roche Pharmaceuticals to obtain exclusive over-the-counter (OTC) ...

Vaccine Market Valued at $93 Billion by 2026

by TVR Staff
market growth
A recent report by Fortune Business Insights projects the value of the world market for vaccines to reach $93.08 billion by ...

GlaxoSmithKline Partners with Viome to Develop New Vaccines

by TVR Staff
research in laboratory
Vaccine manufacturer GlaxoSmithKline (GSK) of the United Kingdom has partnered with Viome, a gut microbiome test company in Seattle, Washington ...

In this section

Search in Archive